Company news
Neovasc Inc news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Neovasc Announces Circulatory System Devices Panel Meeting Date for Neovasc Reducer(TM) Device
July 9, 2020
Neovasc Provides Update on Second Quarter Results
July 6, 2020
Neovasc Reducer(TM) and Tiara(TM) Featured at Leading Industry Virtual Conferences
June 29, 2020
Neovasc Announces Positive Interim Results from REDUCER-I Study
June 26, 2020
Neovasc Regains Compliance with Nasdaq Minimum Market Value Rule
June 25, 2020
Neovasc Announces Closing of $11.5 Million Registered Direct Offering Priced At-The-Market
June 16, 2020
Neovasc Announces $11.5 Million Registered Direct Offering Priced At-The-Market
June 12, 2020
Neovasc Reducer(TM) and Tiara(TM) Program to be Highlighted at Leading Industry Virtual Conferences
June 9, 2020
Neovasc Announces Closing of Final Convertible Debt Issuance for Gross Proceeds of US$5.0 Million
June 4, 2020
Neovasc Reducer Spotlighted in Leading German Public Television Program
June 3, 2020
Neovasc Has Filed for CE Mark for Tiara TA Transapical Mitral Valve Replacement System
May 27, 2020
Neovasc Provides Corporate Update
May 26, 2020
Neovasc Announces Offering of Convertible Debt and Warrants for Gross Proceeds of up to US$5.0 Million, Warrant Exchange Transaction and Repayment of 2017 Convertible Notes and Related Settlement
May 26, 2020
Neovasc Announces First Quarter Financial Results
May 7, 2020
Neovasc Announces Receipt of Nasdaq Extension to Satisfy Market Cap Rule
May 1, 2020
Neovasc to Report First Quarter Financial Results on May 7, 2020
April 23, 2020
Neovasc Announces Fourth Quarter and Full Year 2019 Financial Results
March 30, 2020
Neovasc to Report Fourth Quarter and Full Year 2019 Financial Results on March 30, 2020
March 17, 2020
Neovasc Updates Investors at SVB Leerink 9th Annual Global Healthcare Conference
March 4, 2020
Neovasc Reducer Featured in Peer Reviewed EuroIntervention and PCR Online
March 3, 2020
Neovasc Will Request Nasdaq Hearing After Company Received Expected Delisting Determination From Nasdaq Staff
February 20, 2020
Neovasc to Participate in SVB Leerink 9th Annual Global Healthcare Conference on February 26, 2020
February 18, 2020
Neovasc Achieves Design Freeze for Transfemoral Trans-septal Tiara(TM) Mitral Valve System
February 12, 2020
Neovasc Initiates Independent Inquiry into Trading of Its Shares
February 11, 2020
Neovasc Provides Update on Nasdaq Compliance
February 3, 2020
Neovasc Announces Renewal of German Reimbursement NUB Status 1 Designation for Neovasc Reducer(TM) for Treatment of Refractory Angina
January 31, 2020
Neovasc Announces Executive Steering Committee for Transfemoral Trans-Septal Tiara Program
January 28, 2020
Neovasc Advances New Transfemoral Trans-Septal Tiara Design Concept After Further Successful Tests
January 24, 2020
Neovasc Reducer(TM) for Treatment of Refractory Angina Featured in Multiple Presentations in Germany
January 22, 2020
Updates on Reducer and Tiara Programs Will be Presented at Advanced Cardiovascular Intervention 2020 Meeting
January 21, 2020
Neovasc Receives Administrative Acceptance Review Notification for Premarket Approval Application from FDA for the Neovasc Reducer(TM)
January 15, 2020
Neovasc Inc. Investor Update
January 13, 2020
Neovasc Announces Closing of $10 Million Registered Direct Offering Priced At-The-Market
January 6, 2020
Neovasc Announces $10 Million Registered Direct Offering Priced At-The-Market
January 2, 2020
Neovasc Submits Premarket Approval Application to FDA for Neovasc Reducer(TM)
December 31, 2019
Neovasc Reducer(TM) Featured In National Geographic Magazine
December 17, 2019
Neovasc Named Finalist in Questex's Fierce Innovation Awards Lifesciences Edition 2019
December 4, 2019
Neovasc Reducer(TM) Featured In FOCUS Magazine
November 26, 2019
Neovasc Reducer(TM) Featured During Therapy Development Program in Coburg and Session at Maria Cecilia Hospital in Cotignola
November 22, 2019
Neovasc Tiara(TM) Progress Highlighted at PCR London Valves 2019
November 19, 2019
Neovasc Reducer(TM) Therapy for Refractory Angina Exceeds 200th Patient Milestone in Germany
November 12, 2019
Neovasc Announces Third Quarter 2019 Financial Results
November 7, 2019
Neovasc to Participate in Stifel 2019 Healthcare Conference and Cannacord Genuity 13th Annual MedTech & Diagnostics Forum
November 6, 2019
Neovasc to Provide Update on TF/TS Tiara Program at PCR Valves 2019
November 5, 2019
Neovasc to Submit Full PMA Application for Neovasc Reducer(TM) in 2019
November 1, 2019
Neovasc to Participate in the 28th Annual Credit Suisse Healthcare Conference on Wednesday, November 13, 2019
October 30, 2019
Neovasc to Announce Third Quarter 2019 Financial Results on Thursday, November 7, 2019
October 25, 2019
Neovasc Reducer(TM) for Treatment of Refractory Angina Featured in Sponsored Session at the 40th Annual National Congress of the Italian Society of Interventional Cardiology
October 22, 2019
Neovasc Retains Westwicke, ICR for Integrated Communications Counsel
October 16, 2019
Neovasc Announces Notice of US Patent Granted for Tiara(TM) Transcatheter Device for Treatment of Severe Mitral Regurgitation
October 15, 2019
Decks
The 5 newest of 13 decks. Every deck is listed under its year.
- EuroPCR 2020
Conference · 11 slides · June 2020
- Investor Presentation (January 2015)
Investor deck · 22 slides · January 2015
- Investor Presentation (November 2014)
Investor deck · 23 slides · November 2014
- Investor Presentation (April 2013)
Investor deck · 19 slides · April 2013
- Investor Presentation (May 2012)
Investor deck · 21 slides · May 2012